Rolf Ljung

8.0k citations

170 papers · 5.3k indexed · h-index 42

Impact in

Hematology top 0.1%
- Hemophilia Treatment and Research
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
- Hemostasis and retained surgical items
- Chronic Myeloid Leukemia Treatments
Genetics top 0.5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 158
- Hemophilia Treatment and Research 154
- Blood Coagulation and Thrombosis Mechanisms 75
- Platelet Disorders and Treatments 51
- Hemostasis and retained surgical items 16
- Chronic Myeloid Leukemia Treatments 10
Genetics 35
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 21
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8

Co-authors: Pia Petrini Erik Berntorp Kathelijn Fischer Elena Santagostino H. Marijke van den Berg Massimo Morfini Lilian Tengborn Jan Astermark
Journals: Haemophilia (57 papers)British Journal of Haematology (11 papers)European Journal Of Haematology (11 papers)Thrombosis and Haemostasis (9 papers)Blood (7 papers)
Partner nations: Sweden United Kingdom Germany

In The Last Decade

Rolf Ljung

167 papers receiving 5.1k citations

Peers

Countries citing papers authored by Rolf Ljung

Since Specialization

Citations

This map shows the geographic impact of Rolf Ljung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Ljung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Ljung more than expected).

Fields of papers citing papers by Rolf Ljung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Ljung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Ljung. The network helps show where Rolf Ljung may publish in the future.

Co-authors

The 25 scholars most cited alongside Rolf Ljung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rolf Ljung Line = papers co-authored together Rolf Ljung links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Blood Group O Does Not Increase the Risk of Inhibitors in Severe Haemophilia A: Data from the PedNet Study Group Haemophilia ·Marloes de Kovel, Aimée‐Claire van Haaster, Manuel Carção, Susanna Ranta, Heidi Glosli, Georges‐Étienne Rivard, (unknown), Karin Kurnik, Chris Van Geet, Manuela Carvalho, Nadine G. Andersson, Mutlu Kartal‐Kaess, Rolf Ljung, H. Marijke van den Berg, (unknown)	2025	0
2	F8/F9 variants in the population-based PedNet Registry cohort compared with locus-specific genetic databases of the European Association for Haemophilia and Allied Disorders and the Centers for Disease Control and Prevention Hemophilia A or Hemophilia B Mutation Project Research and Practice in Thrombosis and Haemostasis ·Veerle Labarque, Maria Elisa Mancuso, Mutlu Kartal‐Kaess, Rolf Ljung, Torben Stamm Mikkelsen, Nadine G. Andersson	2023	2
3	Haemophilia A and B – evaluation of the Swedish prophylactic regimen by magnetic resonance imaging Haemophilia ·Björn Lundin, Fariba Baghaei, Margareta Holmström, Pia Petrini, Gunilla Müller, Sven Månsson, Rolf Ljung	2022	5
4	Tailoring care to haemophilia patients' needs: which specialty and when? PubMed ·Massimo Morfini, Gary Benson, Víctor Jiménez‐Yuste, Rolf Ljung, Pier Mannuccio Mannucci, Gianluigi Pasta, Eduardo Remor, Silva Zupančić Šalek	2015	10
5	Joint disease, the hallmark of haemophilia: What issues and challenges remain despite the development of effective therapies? Thrombosis Research ·Thierry Lambert, Günter Auerswald, Gary Benson, Ulla Hedner, Víctor Jiménez‐Yuste, Rolf Ljung, Massimo Morfini, Eduardo Remor, Elena Santagostino, Silva Zupančić Šalek	2014	8
6	Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s Blood ·Kathelijn Fischer, Katarina Steen Carlsson, Pia Petrini, Margareta Holmström, Rolf Ljung, H. Marijke van den Berg, Erik Berntorp	2013	174
7	Origin of Swedish hemophilia A mutations Journal of Thrombosis and Haemostasis ·Christer Halldén, D. Nilsson, Torbjörn Säll, Christina Lind‐Halldén, Annika C. Lidén, Rolf Ljung	2012	13
8	Optimizing joint function: new knowledge and novel tools and treatments Haemophilia ·Paul E. Monahan, Andréa S. Doria, Rolf Ljung, Víctor Jiménez‐Yuste	2012	6
9	Modern treatment options for von Willebrand disease and haemophilia B - What are the benefits for the patients? Thrombosis and Haemostasis ·Paul Giangrande, Mario von Depka, Craig M. Kessler, Christoph Kannicht, Rolf Ljung	2011	0
10	European Initiative to prevent joint damage in haemophilia children with inhibitors (ENJOIH) - a prospective study Haemophilia ·Elena Santagostino, G. Auerswald, Víctor Jiménez‐Yuste, Rolf Ljung, Massimo Morfini, Angiola Rocino, Guy Young	2010	7
11	Mild haemophilia in Sweden Haemophilia ·Caroline Ekholm, E Mattson, Jan Astermark, Rolf Ljung, Erik Berntorp	2010	3
12	Quality of life in haemophilia carriers - preliminary results of the ESCHQoL study Lund University Publications (Lund University) ·Urs C. Steiner, Rolf Ljung, Monika Bullinger, Sylvia von Mackensen	2008	2
13	Third and Fourth Workshops of the European paediatric network for haemophilia management¹ Haemophilia ·F. G. H. Hill, Rolf Ljung	2003	32
14	Comparison of two prophylactic regimens for severe hemophilia: Intermediate dose versus high dose. Data Archiving and Networked Services (DANS) ·Jan Astermark, Johanna G. van der Bom, Rolf Ljung, Erik Berntorp, (unknown), Maarten P. van den Berg	2001	1
15	Factor IX Inhibitors and Anaphylaxis in Hemophilia B The American journal of pediatric hematology/oncology ·Indira Warrier, Bruce M. Ewenstein, Marion A. Koerper, Amy D. Shapiro, Nigel S. Key, Donna DiMichele, Robert Miller, John Pasi, Georges E. Rivard, Steve S. Sommer, Jacob Katz, Frauke Bergmann, Rolf Ljung, Pia Petrini, Jeanne M. Lusher	1997	128
16	Molecular basis of factor xiii deficiency H.Mikkola Fibrinolysis & proteolysis ·Vivien C. Yee, László Muszbek, Martti Syrjälä, Teea Salmi, R. Seitz, R. Egbring, Rolf Ljung, Pia Petrini, J. Ingerslev, D.C. Teller, Laura‐Maria Peltonen, Aarno Palotie	1996	1
17	The feasibility of long-term venous access in children with hemophilia Lund University Publications (Lund University) ·Rolf Ljung, Ann Christine Lindgren, Lilian Tengborn, Pia Petrini	1994	13
18	Prophylactic treatment of severe hemophilia A and B can prevent joint disability Lund University Publications (Lund University) ·Inga Marie Nilsson, Erik Berntorp, Rolf Ljung, Thomas Löfqvist, Holger Pettersson	1994	16
19	Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia Acta Paediatrica ·Rolf Ljung, Pia Petrini, A‐K. Lindgren, Erik Berntorp	1992	50
20	Moderate haemophilia B in a female carrier caused by preferential inactivation of the paternal X chromosome European Journal Of Haematology ·Stefan Kling, Alison J. Coffey, Rolf Ljung, Elsy Sjörin, Inga Marie Nilsson, Lars Holmberg, F. Giannelli	1991	23

About Rolf Ljung

Rolf Ljung is a scholar working on Hematology, Genetics, Molecular Biology, Pediatrics, Perinatology and Child Health and Speech and Hearing, having authored 170 papers that have together received 5.3k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (154 papers), Blood Coagulation and Thrombosis Mechanisms (75 papers), Platelet Disorders and Treatments (51 papers), Cancer-related gene regulation (39 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (21 papers), Hemostasis and retained surgical items (16 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). The work is most often cited by research in Hematology (4.8k citations), Genetics (1.2k citations), Molecular Biology (1.1k citations), Microbiology (58 citations) and Management of Technology and Innovation (63 citations). Rolf Ljung has collaborated with scholars based in Sweden, United Kingdom and Germany. Frequent co-authors include Pia Petrini, Erik Berntorp, Kathelijn Fischer, Elena Santagostino, H. Marijke van den Berg, Massimo Morfini, Lilian Tengborn, Jan Astermark, Erik Berntorp and Victor S. Blanchette. Their work appears in journals such as Haemophilia, British Journal of Haematology, European Journal Of Haematology, Thrombosis and Haemostasis and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact